Physician profile
Craig W Pickren
NPI 1427146174
$505.26
in general payments reported to CMS, 2019-2025
11 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Undersea and Hyperbaric Medicine (Emergency Medicine) provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $50.93 · 2021: $11.41 · 2022: $136 · 2023: $58.25 · 2024: $31.35 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $197.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $120.09 | 2019-2025 | Puraply, Affinity |
| Smith+Nephew, INC. | $95.20 | 2019-2023 | Renasys Go V2 Home |
| Kerecis Limited | $75.10 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Avinger INC. | $42.59 | 2022 | |
| Abbvie INC. | $35.35 | 2023-2024 | |
| Shockwave Medical, INC | $34.32 | 2025 | |
| Averitas Pharma INC. | $28.43 | 2025 | Qutenza |
| Integra Lifesciences Corporation | $26.39 | 2019 | |
| Melinta Therapeutics, LLC | $19.00 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.76 | 2022 | |
| Cardiovascular Systems INC. | $13.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Pickren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.